New injection tested to boost radiation against cervical cancer
NCT ID NCT05570422
Summary
This early-stage study is testing whether a new drug called KRC-01, injected directly into the tumor, can make radiation therapy more effective against locally advanced cervical cancer. The trial will first check the safety of different dosing schedules in 10 patients, then compare the combination treatment to standard radiation therapy in 60 more patients. The main goals are to see if the treatment is safe and if it helps control the cancer better than radiation alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Site 1
Visakhapatnam, India
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site 2
Chandigarh, India
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site 3
Manchester, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site 4
Chiang Mai, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site 5
Bangkok, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.